The families of four elderly people who died while taking an anti-clotting drug have filed a legal complaint against France's drugs safety body and Germany-based drugmaker Boehringer Ingelheim, their lawyers said Wednesday.
The involuntary manslaughter suit alleges the drug was put to market without taking into account its possible effects on the elderly.
It also alleges that France's ANSM drugs and health products safety agency failed to provide proper warnings about the product's potential dangers.
The four victims, aged between 70 and 83, died at the end of last year and in the first three months of 2013 while taking the drug, the families' lawyer Philippe Courtois said.
Pradaxa is a blood thinner prescribed to prevent strokes but it can cause serious internal bleeding and has been linked to a number of deaths.
The complaint alleges that the potential side effects of the drug "were not sufficiently studied, especially in regards to the most fragile patients" such as the elderly and those suffering from kidney problems.
Courtois alleged that older people were under-represented in tests of the drug, "while they are the most exposed" to risks.
But the families' lawyers also urged people not to stop taking the drug without consulting their doctor.
"Pradaxa is not a good product, but it could be a lot more dangerous to stop taking it without medical advice," said another lawyer for the families, Jean-Christophe Coubris.
The complaint also raises concerns that unlike with previous anti-clotting drugs no antidote to Pradaxa has been developed, so there is no way to stop bleeding once it starts.
The ANSM could not be reached for comment.
In a statement, Boehringer Ingelheim said it would "cooperate actively" with a French investigation.
A number of similar lawsuits against Pradaxa have also been filed in the United States.
Explore further: Blood thinner dangerous for patients with artificial heart valves, study finds
© 2013 AFP
Medical Xpress on facebook
Related Stories
Blood thinner dangerous for patients with artificial heart valves, study finds
Sep 26, 2013
(HealthDay)—When used by patients with mechanical heart valves, the blood thinner Pradaxa raises the risk of both dangerous clots and bleeding around the heart, a new study says.
New blood thinner beats older drug for vein clots
Feb 20, 2013
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
FDA: Pradaxa not for patients with mechanical heart valves
Dec 21, 2012
(HealthDay)—The blood thinner Pradaxa should not be used to prevent stroke or blood clots in patients with mechanical heart valves, the U.S. Food and Drug Administration said in a warning issued Wednesday.
Bristol-Myers, Pfizer's Eliquis approved in Japan
Dec 26, 2012
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
France ends alert on diuretic drug after scare
Jun 20, 2013
France's drug watchdog on Thursday ended a 13-day alert over a diuretic used to control dangerously high blood pressure among the elderly after two persons who took the pills died.
Recommended for you
GSK to seek green light for malaria vaccine
Oct 08, 2013
British drug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease.
Overhauling confusing prescription medicine labels
Oct 07, 2013
Northwestern Medicine, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients ...
FDA OKs drug to treat hot flashes in menopausal women
Oct 04, 2013
(HealthDay)—Pfizer Inc. says it has gained U.S. approval for a drug designed to treat menopause-related hot flashes and potentially prevent osteoporosis in postmenopausal women who have a uterus.
Why do doctors abuse prescription drugs? 'Self-medication' is key reason
Oct 04, 2013
Doctors who abuse prescription drugs often do so for "self-medication"—whether for physical or emotional pain or stress relief, reports a study in the October Journal of Addiction Medicine, the official journal of the Am ...
Cultural differences shed light on non-completion of HPV vaccination in girls in low-income families
Oct 04, 2013
Although they are at higher risk for cervical cancer, girls from low-income families are less likely to receive the human papillomavirus (HPV) vaccine that prevents it, and the reasons they are not fully vaccinated differ ...
FDA withdraws arsenic-based animal drug approvals following study
Oct 04, 2013
(Medical Xpress)—At the request of two drug companies, the Food and Drug Administration (FDA) has announced that it will withdraw approvals for three of four arsenic-based drugs currently approved for use in food animal ...
User comments
© Medical Xpress 2011-2013, Phys.org network
The families of four elderly people who died while taking an anti-clotting drug have filed a legal complaint against France's drugs safety body and Germany-based drugmaker Boehringer Ingelheim, their lawyers said Wednesday.
The involuntary manslaughter suit alleges the drug was put to market without taking into account its possible effects on the elderly.
It also alleges that France's ANSM drugs and health products safety agency failed to provide proper warnings about the product's potential dangers.
The four victims, aged between 70 and 83, died at the end of last year and in the first three months of 2013 while taking the drug, the families' lawyer Philippe Courtois said.
Pradaxa is a blood thinner prescribed to prevent strokes but it can cause serious internal bleeding and has been linked to a number of deaths.
The complaint alleges that the potential side effects of the drug "were not sufficiently studied, especially in regards to the most fragile patients" such as the elderly and those suffering from kidney problems.
Courtois alleged that older people were under-represented in tests of the drug, "while they are the most exposed" to risks.
But the families' lawyers also urged people not to stop taking the drug without consulting their doctor.
"Pradaxa is not a good product, but it could be a lot more dangerous to stop taking it without medical advice," said another lawyer for the families, Jean-Christophe Coubris.
The complaint also raises concerns that unlike with previous anti-clotting drugs no antidote to Pradaxa has been developed, so there is no way to stop bleeding once it starts.
The ANSM could not be reached for comment.
In a statement, Boehringer Ingelheim said it would "cooperate actively" with a French investigation.
A number of similar lawsuits against Pradaxa have also been filed in the United States.
Explore further: Blood thinner dangerous for patients with artificial heart valves, study finds
© 2013 AFP
Medical Xpress on facebook
Related Stories
Blood thinner dangerous for patients with artificial heart valves, study finds
Sep 26, 2013
(HealthDay)—When used by patients with mechanical heart valves, the blood thinner Pradaxa raises the risk of both dangerous clots and bleeding around the heart, a new study says.
New blood thinner beats older drug for vein clots
Feb 20, 2013
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
FDA: Pradaxa not for patients with mechanical heart valves
Dec 21, 2012
(HealthDay)—The blood thinner Pradaxa should not be used to prevent stroke or blood clots in patients with mechanical heart valves, the U.S. Food and Drug Administration said in a warning issued Wednesday.
Bristol-Myers, Pfizer's Eliquis approved in Japan
Dec 26, 2012
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
France ends alert on diuretic drug after scare
Jun 20, 2013
France's drug watchdog on Thursday ended a 13-day alert over a diuretic used to control dangerously high blood pressure among the elderly after two persons who took the pills died.
Recommended for you
GSK to seek green light for malaria vaccine
Oct 08, 2013
British drug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease.
Overhauling confusing prescription medicine labels
Oct 07, 2013
Northwestern Medicine, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients ...
FDA OKs drug to treat hot flashes in menopausal women
Oct 04, 2013
(HealthDay)—Pfizer Inc. says it has gained U.S. approval for a drug designed to treat menopause-related hot flashes and potentially prevent osteoporosis in postmenopausal women who have a uterus.
Why do doctors abuse prescription drugs? 'Self-medication' is key reason
Oct 04, 2013
Doctors who abuse prescription drugs often do so for "self-medication"—whether for physical or emotional pain or stress relief, reports a study in the October Journal of Addiction Medicine, the official journal of the Am ...
Cultural differences shed light on non-completion of HPV vaccination in girls in low-income families
Oct 04, 2013
Although they are at higher risk for cervical cancer, girls from low-income families are less likely to receive the human papillomavirus (HPV) vaccine that prevents it, and the reasons they are not fully vaccinated differ ...
FDA withdraws arsenic-based animal drug approvals following study
Oct 04, 2013
(Medical Xpress)—At the request of two drug companies, the Food and Drug Administration (FDA) has announced that it will withdraw approvals for three of four arsenic-based drugs currently approved for use in food animal ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment